Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management - GBI Research Reports

Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management

Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management - GBI Research Reports
Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management
Published Aug 22, 2012
39 pages — Published Aug 22, 2012
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, leading business intelligence provider has released its latest report, Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management, which provides insights into the key applications of cloud computing in the research, development and sales effectiveness within the pharmaceutical industry. The report provides an understanding of technological concepts in cloud computing, including cloud computing service models, deployment models and key stakeholders. Information on the major players in the cloud computing space is followed by an overall assessment of the technology in terms of benefits and restraints. Applications of cloud computing in the pharmaceutical industry are explained in the next section, with a focus on next-generation sequencing, bioinformatics, transfer of information across the sales force and clinical trials data management.

This report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Researchs team of industry experts.

GBI Research analyses reveals that cloud computing has managed to change the invention, development, deployment updating and maintenance of information technology (IT) services. While the per-unit cost of computing has decreased due to the exponential increase in the power of modern machines, the cost of managing IT infrastructure has increased over the same time period. This is mainly due to the penetration of systems within the organization which has significantly increased the complexity of the entire infrastructure. Cloud computing promises to deliver existing as well as new functionalities of IT, coupled with a significant reduction in costs for deploying these functionalities.

Scope

- A brief technical understanding of cloud computing services
- Review of cloud computing service models, deployment models and role of major stakeholders
- Dedicated section on applications of cloud computing across the pharmaceutical industry value chain
- An understanding the benefits and restraints of cloud computing
- The report also covers information on the leading market players and the competitive landscape, including established companies, technology providers and innovative companies in the cloud computing space

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the use of cloud computing in healthcare
- Understand the potential areas of application across the value chain.
- Identify key services and applications which can be hosted on the cloud
- Identify the key players in the cloud computing space

  
Source:
Document ID
GBIHC217MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents53
  List of Tables71
  List of Figures71
Introduction82
Cloud Computing in Pharmaceutical Research and Development Key Technological Concepts105
  Core Technologies101
    Virtualization101
    Multi-tenancy101
    Web Services101
  Cloud Computing Service Models111
    Infrastructure as a Service (IaaS)111
    Platform as a Service (PaaS)111
    Software as a Service (SaaS)121
  Cloud Computing Deployment Models131
  Stakeholders141
    End-users/Consumers141
    Providers141
    Regulators141
    Enablers141
Cloud Computing in Pharmaceutical Research and Development Competitive Landscape157
  Established Players151
    International Business Machines Corporation (IBM)151
    Google161
    Microsoft171
  Technology Providers181
    Apache181
    EMC191
  Innovative Companies201
    Amazon.com201
    Salesforce.com211
Cloud Computing in Pharmaceutical Research and Development Technology Assessment224
  Benefits of Clouds231
    Cost Savings231
    Immediate Access to Resources231
    Lower Barriers to Innovation231
    Scalability of Services231
    New Classes of Applications and Services241
  Restraints to the Cloud241
    Security241
    Privacy and Data Location241
    Dependency on the Internet241
    System Availability and Level of Service241
    Migration of Current Applications251
Cloud Computing in Pharmaceutical Research and Development Applications2611
  Biomedical Cloud261
    Adequate Security Measures271
    Communication with Private Clouds271
    On-demand Scalability281
    Data Transfer281
    Interaction with Other Clouds281
  Next-Generation Sequencing281
    Case Study Adoption of Cloud Computing by Merck (the US)291
  Bioinformatics and Genomics302
  In Silico Research through Cloud Computing321
    The Data Layer321
    The System Layer331
    The Service Layer342
  Information Dissemination361
  Cloud Computing for Management of Clinical Trials361
Cloud Computing in Pharmaceutical Research and Development Appendix373
  Market Definitions371
  Abbreviations371
  Bibliography371
  Research Methodology382
    Coverage381
    Secondary Research381
    Primary Research391
  Expert Panel Validation391
  Contact Us391
  Disclaimer391

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management" Aug 22, 2012. Alacra Store. May 05, 2025. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Cloud-Computing-in-Pharmaceutical-Research-and-Development-Virtualization-of-Data-through-the-Cloud-Optimizes-Next-Generation-DNA-Sequencing-and-Clinical-Trials-Data-Management-2115-483>
  
APA:
GBI Research Reports. (2012). Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management Aug 22, 2012. New York, NY: Alacra Store. Retrieved May 05, 2025 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Cloud-Computing-in-Pharmaceutical-Research-and-Development-Virtualization-of-Data-through-the-Cloud-Optimizes-Next-Generation-DNA-Sequencing-and-Clinical-Trials-Data-Management-2115-483>
  
US$ 3,500.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.